This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Okada, J Articles by Kondo, H Search for Related Content PubMed PubMed Citation Articles by Okada, J Articles by Kondo, H Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLECALCIFEROL Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Prevalence of soft tissue calcifications in patients with SLE and effects of alfacarcidol

M Nomura

Division of Rheumatology, Department of Internal Medicine Kitasato University School of Medicine

M Shirataka

Department of Medical Informatics, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan

H Kondo

Division of Rheumatology, Department of Internal Medicine Kitasato University School of Medicine

Objective: To clarify the prevalence and etiology of ectopic calcification in patients with systemic lupus erythematosus (SLE), especially under the active vitamin D₃ administrations and to reveal the risk factors of ectopic calcification.

Methods: Sixty patients with SLE, excluding the patients on dialysis were studied. We examined radiographs of hands, forearms, upper and lower extremities, and pelvises of all patients to evaluate ectopic calcification.

Results: The prevalence of ectopic calcification in SLE was 40% (24 out of 60 patients), found in 6.7% (4 patients) in peripheral arteries, 33.3% (20 patients) in periarticular area and 16.7% (10 patients) in other soft tissues. The incidence of lupus nephritis and nephrotic syndrome were significantly higher (respectively: P = 0.0144 and P = 0.0348) in the calcification-positive than negative group. Total protein levels (7.04 0.6 g =dl) of patients in the calcification-positive group were decreased significantly (P = 0.0056) compared with 7.48 0.55 g =dl in the negative group. However, other biochemical parameters were not significantly different between the two groups. Sixty-three percent of the SLE patients with ectopic calcification received alfacarcidol, which is significantly (P = 0.0007) higher than the 19% in patients without calcification.

Conclusion: It is suggested that the alfacarcidol therapy and lupus nephritis could increase the risk of ectopic calcification in SLE patients.

Key Words: ectopic calcification • active vitamin D3 • systemic lupus erythematosus • lupus nephritis

Lupus, Vol. 8, No. 6, 456-461 (1999)
DOI: 10.1177/096120339900800608


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. A. Mandelbrot, P. W. Santos, R. K. Burt, Y. Oyama, G. A. Block, S. N. Ahya, R. M. Rosa, and A. E. Traynor Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2679 - 2684. [Abstract] [Full Text] [PDF]

				L V P. Korlipara, P. Kiely, I. Bodi, and F. Schon Devastating calcinosis in a patient with adult onset myositis J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 1005 - 1006. [Full Text] [PDF]

				C. Palazzi, E. D'Amico, D. De Santis, V. Pace-Palitti, and A. Petricca Superficial calcinosis related to bleeding in a patient with undifferentiated connective tissue disease and primary biliary cirrhosis Rheumatology, August 1, 2001; 40(8): 947 - 948. [Full Text] [PDF]